Archive for 'October,2013'

Breakthrough treatment for neuroendocrine tumours (NETs) is now available in Belgium (Bordet Institute)

Breakthrough treatment for neuroendocrine tumours (NETs) is now available in Belgium (Bordet Institute)

For the first time, a new form of targeted radiotherapy, or PRRT (Peptide Receptor Radio Therapy) using Lutetium-177 octreotate is available in Belgium. Thanks to a long-term endeavour of logistics, processes and national approval issues, this [...]

Quality Assistance (Thuin, Belgium) faces challenge of attracting qualified personnel

Quality Assistance (Thuin, Belgium) faces challenge of attracting qualified personnel

Now hiring! Quality Assistance (QA), a contract research organization (CRO) dedicated to 3rd generation medicines, has announced a €4.5 million investment over the next 18 months and a commitment to creating 15 new jobs by the [...]

Cardio3 BioSciences named Trends-Tendances Business Tour 2013 Most Innovative Company for Brabant Walloon

Cardio3 BioSciences named Trends-Tendances Business Tour 2013 Most Innovative Company for Brabant Walloon

Cardio3 BioSciences (Mont-Saint-Guibert, Belgium) has been named winner of the Trends-Tendances Business Tour 2013 Award in the “Innovation” category for the Brabant Walloon region.  The Business Tour showcases three companies in each province in the country in [...]

Dr. Andrei Turtoï of the “Metastasis Research Lab” (ULg): laureate of the ASIP 2013 Experimental Pathologist-in-Training Award

Dr. Andrei Turtoï of the “Metastasis Research Lab” (ULg): laureate of the ASIP 2013 Experimental Pathologist-in-Training Award

Dr. Andrei Turtoï is the 2013 recipient of the prestigious “ASIP Experimental Pathologist-in-Training Award”, presented by the American Society for Investigative Pathology  (http://www.asip.org/awards/epit.cfm). The EPIT Award1 is presented to an ASIP trainee member who is a post-doctoral [...]